Children's Healthcare of Atlanta
choa.orgTotal trials
95
Active
3
Phase 3
1
Total enrollment
13,729
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Gabapentin | — | — | — | — | — | 1 |
Next readouts
- 2019-12-31
Top conditions
- Congenital Disorders49
- Critical Illness3
- Congenital Heart Disease2
- Pain2
- Congenital Heart Defects2
- Burnout2
- Respiratory Syncytial Virus Infections1
- Tonsillitis1
Frequently asked questions about Children's Healthcare of Atlanta
- How many clinical trials does Children's Healthcare of Atlanta have on ClinicalTrials.gov?
- Children's Healthcare of Atlanta is listed as the lead sponsor on 95 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Children's Healthcare of Atlanta's trials are in Phase 3?
- 1 of Children's Healthcare of Atlanta's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Children's Healthcare of Atlanta focus on?
- Children's Healthcare of Atlanta's most-studied conditions on ClinicalTrials.gov are Congenital Disorders, Critical Illness, Congenital Heart Disease, Pain, Congenital Heart Defects.
- When are Children's Healthcare of Atlanta's next clinical trial readouts?
- Children's Healthcare of Atlanta has 1 upcoming primary-completion readout tracked here; the soonest is “Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy”, expected around 2019-12-31.